CLIENT LOGIN

The FLEX real world data platform explores new gene expression profiles and investigator-initiated protocols in early stagebreast cancer

PUBLICATION: SABCS 2020 AUTHORS: Laura Lee, Sami Diab, Julie Barone, Read More

2020-12-29T08:32:41-08:00December 29th, 2020|Evidence, Uncategorized|

The 70-gene signature (MammaPrint) accurately predicts distant breast cancer recurrence risk in older patients

PUBLICATION: SABCS 2020 AUTHORS:Iris Noordhoek, Esther Bastiaannet, Ersan Lujinovic, Laura Read More

2021-03-08T16:26:00-08:00December 10th, 2020|Evidence, Uncategorized|

MammaPrint and BluePrint NGS Results are Robust and Accurate for Patients with Early Stage Breast Cancer

PUBLICATION: AMP 2020 AUTHORS: Douglas Kingma, Kasey Lawrence, Sahra Uygun, Read More

2020-11-17T08:00:16-08:00November 17th, 2020|Evidence, Uncategorized|
Go to Top